Elekta opens new Asia Pacific office

TriMed Staff | | Health Imaging | Oncology Imaging
Radiation oncology device manufacturer Elekta has opened an office in South Korea, marking its seventh Asia Pacific office.

The office, located in Bundang, South Korea, will allow the Stockholm-based company to expand its radiosurgery and cancer care offerings within the region, stated Elekta. The company also has Asia Pacific offices in Singapore, India, Hong Kong, Tokyo, Shanghai, Beijing and Australia.

TriMed Staff

Related Content

New radiopharmaceutical targeted at gastrointenstinal cancers yields impressive results
New PET method combines antibody with radioactive isotope to improve lung cancer detection
VI-RADS threshold, imaging features predict bladder cancer invasiveness with nearly 100% accuracy
PHOTO GALLERY: thyroid nodule imaging
Tiny 'water bears' may hold key to reducing radiation-induced side effects
High-intensity focused ultrasound could allow prostate cancer patients to avoid surgery

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.